Balyasny Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.54M | Sell |
797,100
-601,397
| -43% | -$4.94M | 0.01% | 802 |
|
|
2025
Q1 | $10M | Buy |
1,398,497
+211,395
| +18% | +$1.51M | 0.02% | 648 |
|
|
2024
Q4 | $9.18M | Buy |
1,187,102
+66,993
| +6% | +$518K | 0.01% | 692 |
|
|
2024
Q3 | $11.7M | Buy |
1,120,109
+313,394
| +39% | +$3.29M | 0.02% | 613 |
|
|
2024
Q2 | $9.44M | Buy |
806,715
+379,760
| +89% | +$4.44M | 0.02% | 657 |
|
|
2024
Q1 | $9M | Buy |
426,955
+230,882
| +118% | +$4.86M | 0.02% | 715 |
|
|
2023
Q4 | $3.52M | Sell |
196,073
-591,550
| -75% | -$10.6M | 0.01% | 879 |
|
|
2023
Q3 | $13M | Buy |
787,623
+238,677
| +43% | +$3.93M | 0.03% | 551 |
|
|
2023
Q2 | $11M | Buy |
548,946
+172,646
| +46% | +$3.45M | 0.02% | 569 |
|
|
2023
Q1 | $7.12M | Buy |
376,300
+375,427
| +43,004% | +$7.1M | 0.02% | 702 |
|
|
2022
Q4 | $19.8K | Buy |
+873
| New | +$19.8K | ﹤0.01% | 2043 |
|
|
2019
Q3 | – | Sell |
-152,521
| Closed | -$7.84M | – | 1352 |
|
|
2019
Q2 | $7.84M | Buy |
152,521
+144,504
| +1,802% | +$7.42M | 0.05% | 410 |
|
|
2019
Q1 | $459K | Buy |
+8,017
| New | +$459K | ﹤0.01% | 1124 |
|
|
2018
Q4 | – | Sell |
-65,583
| Closed | -$4.95M | – | 1523 |
|
|
2018
Q3 | $4.95M | Sell |
65,583
-23,937
| -27% | -$1.81M | 0.02% | 553 |
|
|
2018
Q2 | $6.42M | Sell |
89,520
-53,536
| -37% | -$3.84M | 0.03% | 501 |
|
|
2018
Q1 | $4.27M | Buy |
+143,056
| New | +$4.27M | 0.02% | 631 |
|